Corcept Therapeutics Incorporated (CORT) — Cash Flow Reinvestment Rate
Corcept Therapeutics Incorporated (CORT) has a Cash Flow Reinvestment Rate of 0.31x as of December 2025, reinvesting $11.84 Million (capex $50.00K plus investments $-11.79 Million) from operating cash flow of $38.45 Million. Explore Corcept Therapeutics Incorporated (CORT) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Corcept Therapeutics Incorporated Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Corcept Therapeutics Incorporated across 11 annual periods. Also explore CORT total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Corcept Therapeutics Incorporated (2015–2025)
Year-by-year capital reinvestment analysis for Corcept Therapeutics Incorporated. For live market cap and broader valuation context, see CORT market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | $70.18 Million | $142.00 Million | $211.00K | ▼ -45.5% |
| 2024 | 0.91x | $179.78 Million | $198.07 Million | $2.17 Million | ▲ +103.3% |
| 2023 | 0.45x | $56.71 Million | $127.04 Million | $139.00K | ▼ -53.2% |
| 2022 | 0.95x | $114.74 Million | $120.32 Million | $413.00K | ▲ +16.8% |
| 2021 | 0.82x | $137.06 Million | $167.89 Million | $469.00K | ▲ +4.0% |
| 2020 | 0.78x | $119.26 Million | $151.97 Million | $1.24 Million | ▼ -9.3% |
| 2019 | 0.87x | $117.83 Million | $136.12 Million | $1.09 Million | ▲ +10.3% |
| 2018 | 0.78x | $90.77 Million | $115.67 Million | $298.00K | ▼ -34.9% |
| 2017 | 1.21x | $73.46 Million | $60.94 Million | $419.00K | ▲ +5613.9% |
| 2016 | 0.02x | $388.00K | $18.39 Million | $194.00K | ▼ -99.9% |
| 2015 | 23.34x | $73.05 Million | $3.13 Million | $17.00K | — |